Reynolds files lawsuit in California over tobacco products

May.15.2023
Reynolds files lawsuit in California over tobacco products
Reynolds Tobacco files lawsuit in California to defend its non-menthol tobacco products against flavor ban allegations.

On May 12th, Convenience Store News reported that Reynolds Tobacco filed a lawsuit against officials, including California Attorney General Robert Bonta, in response to several notices issued by Bonta alleging that Reynolds Tobacco and certain brands under the Empire Tobacco umbrella "presumptively" marketed flavored tobacco products.


Renault believes that the new product complies with California law.


Tobacco company Reynolds American Inc. has announced that it is taking action to maintain the availability of its legal "non-menthol" tobacco products in the California market. The company filed a lawsuit in California court seeking declaratory and injunctive relief, including the overturning of warning notifications from California authorities.


Renault Tobacco has expressed its support for its new products and believes that they comply with California's laws and can continue to be sold. Renault stated that it had followed all applicable pre-market regulatory requirements before launching these products for sale.


The company's statement stated:


The new Camel and Newport brand tobacco products do not have any discernible flavor or scent other than tobacco, and explicitly state that they are non-menthol on the market.


Renault Tobacco believes that the notification from the California Attorney General's office failed to acknowledge the fact that the newly launched product is prominently labeled as non-menthol and is being sold in the market.


California Attorney General Accuses Reno of Violating Flavoring Ban with New Product.


Previously, California's Attorney General, Xavier Becerra, issued warning letters to Reynolds and Imperial Tobacco stating that California law enforcement officials discovered through a review of cigarette packaging and promotional materials that several products were "presumed to be flavored products in violation of California's flavor ban.


The California Attorney General's office has identified seven products from R.J. Reynolds Tobacco, including Camel Crush Oasis Silver, Camel Crush Oasis Blue, Camel Crush Oasis Green, Camel Crisp, Newport EXP Non-Menthol Mix, Newport EXP Non-Menthol Max, and Newport Non-Menthol Green, as "flavored" tobacco products. Similarly, two products from Imperial Tobacco, Kool Non-Menthol and Kool Blue Non-Menthol, have been identified as "flavored" tobacco products as well.


These two companies are required to respond to these notices before June 23rd.


The Battle Against Flavored Tobacco in California.


On November 8th, 2022, California approved Proposition 31 with approximately 62.3% of voters in favor and 37.7% against. Proposition 31 upholds the state law banning the sale of flavored tobacco, including menthol.


The vote result was immediately met with opposition from tobacco companies, with companies such as Renault suing the California government in the US Supreme Court. However, on December 12th, the US Supreme Court rejected the plea of multiple tobacco companies to halt the implementation of the state's ban on the sale of flavored tobacco products.


According to Renault, the company has repeatedly urged law enforcement officials in California to take action against illegal and unregulated disposable electronic cigarettes that are being smuggled into the state from unknown sources through its ports.


Reference:


Reynolds has initiated legal action in California with the aim of safeguarding the legal sale and distribution of its tobacco products.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | SKE Launches FRESA PRO in the U.S., Introducing Fresh Lock Technology for E-Liquid Management in High-Capacity Vapes
Product | SKE Launches FRESA PRO in the U.S., Introducing Fresh Lock Technology for E-Liquid Management in High-Capacity Vapes
Shenzhen SKE Technology has launched the FRESA PRO in the United States, a high-capacity rechargeable disposable vape featuring Fresh Lock electromagnetic valve supply control technology. The device combines a claimed capacity of up to 40,000 puffs, dual mesh coils, dual output modes and a transparent tank design. The launch reflects the high-capacity disposable vape segment’s shift from puff-count competition toward improved e-liquid management and device-level experience.
Aug.03
UK PM Andy Burnham Shifts Business Rates Policy, Supporting Hospitality While Raising Pressure on Vape Shops
UK PM Andy Burnham Shifts Business Rates Policy, Supporting Hospitality While Raising Pressure on Vape Shops
UK Prime Minister Andy Burnham’s government is adjusting business rates policy to support hospitality businesses while some other sectors, including vape retailers, face higher operating cost pressures. According to Streamline Feed, AJ Bell and other reports, the policy shift reflects a redistribution of business rate burdens as the government seeks to support sectors facing economic pressure. For UK vape shops, the change comes amid a broader regulatory environment shaped by the disposable vape ban, the upcoming Vaping Products Duty and increased compliance requirements.
News
Jul.24
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
Malaysia Police Plan Saliva Tests at Roadblocks to Detect Synthetic Drugs Mixed Into Vape Liquids
Malaysia Police Plan Saliva Tests at Roadblocks to Detect Synthetic Drugs Mixed Into Vape Liquids
Malaysian police plan to use saliva test kits at roadblocks to detect drivers using synthetic liquid drugs marketed as “Piu Piu” and “Magic Mushroom,” substances that authorities say are mixed into vape liquids and inhaled through e-cigarette devices, raising road-safety concerns and adding pressure on vape regulation.
Jun.29
Reuters: India Seeks to Dismiss Adani Nicotine Pouch Challenge as Mumbai Airport Dispute Moves to Court
Reuters: India Seeks to Dismiss Adani Nicotine Pouch Challenge as Mumbai Airport Dispute Moves to Court
Reuters reported on July 13, 2026, that India is seeking to dismiss Adani Airports’ legal challenge over nicotine pouch sales at Mumbai International Airport’s duty-free shops. Adani denies wrongdoing and argues that existing drug and cosmetics regulations do not apply to duty-free sales or nicotine pouches.
Innovation
Jul.14 by 2Firsts Perspectives
Pennsylvania Updates ENDS Certification List as Chinese-Linked Manufacturers Enter State Review
Pennsylvania Updates ENDS Certification List as Chinese-Linked Manufacturers Enter State Review
Pennsylvania’s June 26 Pending ENDS Certifications list includes 23 manufacturers under review, including Shenzhen Smoore, Shenzhen IVPS, YME Technology and China-linked Boulder International. The list shows state-level vape regulation moving beyond retail brands toward manufacturer-based market access alongside FDA oversight.
Regulations
Jul.06 by 2Firsts Perspectives